Condition: Multiple Sclerosis · Multiple Sclerosis, Relapsing-Remitting · Multiple Sclerosis, Primary Progressive · Sponsor: University Hospital, Basel, Switzerland
This prospective cohort study is part of the Clinnova programme and aims to (i) identify clinical imaging and omics characteristics associated with early Multiple Sclerosis (MS) and with transitioning phases to progressive MS, as well as (ii) to investigate digital biomarkers allowing the continuous clinical monitoring of those patients.
This description comes directly from the study's public registry record.
Bebeka Cosandey (Clinnova:Scientific Project Lead), PhD · +41 79 961 26 31 · bebeka.cosandey@usb.ch
Always discuss trial participation with your own doctor first.
| Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) | Basel, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06526364